Lorenzo, Carlos
7 papers on CoChatORCID 0000-0001-7080-765X
Most cited papers
- Verified
Disposition Index, Glucose Effectiveness, and Conversion to Type 2 Diabetes
Lorenzo, C., Wagenknecht, L. E., Rewers, M. J., Karter, A. J., Bergman, R. N., Hanley, A. J. G., & Haffner, S. M. (2010) · Diabetes Care
Diabetes, Cardiovascular Risks, and LipoproteinsPancreatic function and diabetes
Cited by 145
- Verified
Differential effects of metformin on age related comorbidities in older men with type 2 diabetes
Wang, C.-P., Lorenzo, C., Habib, S. L., Jo, B., & Espinoza, S. E. (2017) · Journal of Diabetes and its Complications
Metabolism, Diabetes, and CancerDiabetes Treatment and Management
Cited by 134
- Verified
Long-term effects of metformin on diabetes prevention: identification of subgroups that benefited most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
Diabetes Prevention Program Research Group, Nathan, D. M., Knowler, W. C., Edelstein, S., Crandall, J. P., Dabelea, D., Goldberg, R. B., Kahn, S. E., Mather, K. J., Trandafirescu, G., et al. (2019) · Diabetes Care
Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 128
- Verified
Relation of Direct and Surrogate Measures of Insulin Resistance to Cardiovascular Risk Factors in Nondiabetic Finnish Offspring of Type 2 Diabetic Individuals
Lorenzo, C., Haffner, S. M., Stančáková, A., & Laakso, M. (2010) · The Journal of Clinical Endocrinology & Metabolism
Diabetes, Cardiovascular Risks, and LipoproteinsPancreatic function and diabetes
Cited by 92
- Verified
The impact of physical activity on the prevention of type 2 diabetes: Evidence and lessons learned from the Diabetes Prevention Program, a long-standing clinical trial incorporating subjective and objective activity measures
Kriska, A. M., Rockette-Wagner, B., Edelstein, S. L., Bray, G. A., Delahanty, L. M., Hoskin, M. A., Horton, E. S., Venditti, E. M., Knowler, W. C., DPP Research Group, et al. (2021) · Diabetes Care
Physical Activity and HealthDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 70
- Verified
Performance Characteristics of the New Definition of Diabetes
Lorenzo, C., & Haffner, S. M. (2010) · Diabetes Care
Diabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 53
- Verified
The Diabetes Prevention Program and Its Outcomes Study: NIDDK’s Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact
Crandall, J. P., Dabelea, D., Knowler, W. C., Nathan, D. M., Temprosa, M., DPP Research Group, Bray, G. A., Gadde, K. M., Culbert, I. W., Arceneaux, J., et al. (2025) · Diabetes Care
Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management
Cited by 29
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free